Dr. Robert William Balsiger, DO

Dr. Balsiger practices at Las Vegas Neurology in Las Vegas, Nevada.

Dr. Balsiger's NPI, 1083935811, was assigned on June 16, 2010. Dr. Balsiger graduated from Touro University Nevada in 2010. Dr. Balsiger holds Nevada license DO1855.

Dr. Balsiger's primary practice is Las Vegas Neurology, at 2020 Wellness Way, Las Vegas, NV 89106. The practice phone is (702) 432-2233.

Dr. Balsiger's primary practice is Las Vegas Neurology in Las Vegas, Nevada. The medical group on file is Las Vegas Neurology Center. Dmand AI also links Dr. Balsiger to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balsiger practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Balsiger's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Balsiger is board certified in neurology by the AOA Board of Neurology and Psychiatry. Dr. Balsiger is licensed in Nevada.

Dmand AI lists carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury, lower back pain and migraine and chronic headache among the conditions Dr. Balsiger treats.

CMS data shows 8,876 Medicare services from Dr. Balsiger across 32 procedure codes in 2024, for 1,134 Medicare patients. Medicare paid $645,367 for them.

CMS counts 1,134 Medicare patients who saw Dr. Balsiger in 2024. The largest group is 65 to 74, with 462 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balsiger's median patient age at 71, with 63% women.

In 2024, Dr. Balsiger wrote 1,747 Medicare Part D claims for 418 patients. 75% of them were for generic drugs. CMS names the drug for 1,538 of them, across 33 drugs with 11 or more claims each, at $2,024,723 in total drug cost. In 2023, CMS named 1,620 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 16 out of 100 for Dr. Balsiger for performance year 2024, reported individually. Dr. Balsiger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Balsiger as offering telehealth.

Dmand AI links 5 papers to Dr. Balsiger, published from 2015 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Mouth Neoplasms and Smoking. Dr. Balsiger's most frequent co-authors are Ayham Al Afif, MD, MS, Alan Alexander Arismendez, DO and Nicholas Charles Cameron, DO.

CMS Open Payments shows 915 general payments to Dr. Balsiger from 72 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $4,050.

Dr. Balsiger graduated from Touro University Nevada in 2010. Dr. Balsiger is a member of AOA.

Dr. Balsiger is in network with 13 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.